Physician profile
David Levitan
NPI 1851403281
$792.65
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.79 · 2022: $169 · 2023: $304 · 2024: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $222.50 | 2022-2023 | Impella |
| Medtronic, INC. | $161.87 | 2024 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $141.74 | 2022-2024 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $95.69 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $41.58 | 2021-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $41.00 | 2023 | |
| Daiichi Sankyo INC. | $21.81 | 2024 | Injectafer |
| Merck Sharp & Dohme LLC | $21.38 | 2023 | Verquvo |
| Kls-Martin L.P. | $15.31 | 2022 | |
| Amgen INC. | $15.13 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $14.64 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Levitan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.